NAVA Helmet in Pediatric Respiratory Failure

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE3

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-06-30

Study Completion Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Neurally Adjusted Ventilatory Assist (NAVA) is a new form of partial support wherein the machine applies positive pressure throughout inspiration in proportion to the electrical activity of the diaphragm (EAdi), Because ventilator functioning and cycling are under control of the patient's respiratory drive and rhythm, NAVA has the potential to enhance patient-ventilator interaction ensuring synchrony and minimizing the risk of over-assistance. Among different interfaces, the pediatric helmet is better tolerated than facial or nasal mask, thus requiring less sedation and allowing more prolonged ventilatory assistance (5-6).To date, no data exist on the use of NAVA in infants during noninvasive ventilation. The aim of this physiological study is to compare patient-ventilator interaction in infants receiving NIV by NAVA and Pressure Support Ventilation (PSV) with helmet.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Adjusted Ventilatory Assist (NAVA-NIV) in Infants: Short-term Physiological Study

NCT02043990

Acute Respiratory Failure

UNKNOWN NA

Noninvasive NAVA Versus Flow-triggered Noninvasive Pressure Support in Pediatric Respiratory Failure

NCT03697863

Acute Respiratory Failure

UNKNOWN

Neurally Adjusted Ventilatory Assist (NAVA) in NonInvasive Ventilation (NIV)

NCT01426178

Respiratory Insufficiency

COMPLETED PHASE1

Neurally Adjusted Ventilatory Assist (NAVA) in Pediatric Patients

NCT01056939

Ventilation

COMPLETED NA

Impact of Neurally Adjusted Ventilator Assist (NAVA) Mode on Patient Ventilator Asynchrony Using Helmet

NCT01161875

Non-Invasive Positive-Pressure Ventilation

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Neurally Adjusted Ventilatory Assist (NAVA) is a new form of partial support wherein the machine applies positive pressure throughout inspiration in proportion to the electrical activity of the diaphragm (EAdi), as assessed by trans-esophageal electromyography (1). Because ventilator functioning and cycling are under control of the patient's respiratory drive and rhythm, NAVA has the potential to enhance patient-ventilator interaction ensuring synchrony and minimizing the risk of over-assistance. A high incidence of asynchrony events has been demonstrated to have a significant clinical impact by favouring weaning failure and longer duration of mechanical ventilation (2). NAVA has been implemented safely in animals, in healthy volunteers and in critically ill adults and has been shown to improve patient-ventilator synchrony, to limit excessive airway pressure and tidal volume, and to unload the respiratory muscles in tracheally intubated patients (1,3,4). Moreover NAVA was found to be effective in delivering non-invasive ventilation (NIV) even when the interface was excessively leaky (75% leak) with reduced positive end-expiratory pressure (3). With these conditions, NAVA was able to unload the respiratory muscles and preserve gas exchange, while maintaining synchrony to respiratory demand. Data from medical literature from our group demonstrate that the pediatric helmet was better tolerated than facial mask , required less sedation an allowed more prolonged ventilatory assistance due to better tolerance (5-6). To date, no data exist on the use of NAVA in infants during noninvasive ventilation. The aim of this physiological study is to compare patient-ventilator interaction in infants receiving NIV by NAVA and Pressure Support Ventilation (PSV). Equipment. NAVA and conventional PSV is provided by the Servo-I ventilator (Maquet Critical Care, Solna, Sweden). Electrical activity of the diaphragm (EAdi) is obtained using an array of nine miniaturized electrodes (spaced 6 mm apart) mounted on a conventional (5.5F) feeding tube (Maquet Critical Care AB, Solna, Sweden; Neurovent Research Inc, Toronto, Canada), and positioned in the lower esophagus at the level of the diaphragm. Confirmation of appropriate placement is achieved by viewing the online electrical displays from the catheter. The presence of a good quality EAdi trace with p waves displayed by the central electrodes indicates optimal positioning, with the array spanning the diaphragm equally in both caudal and cranial directions. A pediatric helmet is used as interface between the patient and the ventilator. Tidal volume , airway pressure and flow trace are recorded with the Servo I NAVA Tracker acquisition system.

Experimental protocol. Enrolled patients, after a stabilization period with oxygen therapy and standard medical treatment (antibiotics, steroids, Inhaled beta 2 agonists), receive two 60-minutes ventilatory trials delivered by pediatric helmet.

After a baseline trial on PSV conventional , children are allocated to receive 1 trial NAVA NIV and 1 trial PSV conventional. The sequence of the two ventilatory trials are randomized according to sealed opaque envelops.

Ventilatory trials are as follows:

1. NAVA-NIV
2. PSV conventional . The first 15 mins of each period are considered as a wash out period and patients are carefully observed for any reactions or problems occurring for the technique. After the first 15 mins period, data recording for the study are started.

NAVA and PSV level are set by the attending physician in order to obtain a Tidal Volume (TV) 6-8 ml/kg, peripheral oxygen saturation (SpO2) \> 94%, Respiratory Rate (RR) \< +/-2 SD for age. Sedation and analgesia are provided according to standardized PICU protocols, if needed and are not changed during the two study windows for the same patient.

Monitoring .All infants are monitored as follow: SpO2, and EKG continuously; arterial blood pressure every 15 min; arterial blood gases at enrolment and once for each trial. The total amount of drug needed for sedation and/or complications (intolerance to the interface, leaks, gastric distension) are also recorded.

Statistics. No data are available at the moment in medical literature in infants. Based on retrospective data from adult literature, the predicted reduction in the primary end point (AI) with NAVA versus Conventional flow triggered PSV, is around 20%. The power analysis indicated a sample size of 12 patients was needed to demonstrate a 20% reduction in the AI between the two ventilator modes with an alfa and beta risk of 005 and 0.2 respectively. Sample size calculation has been performed with GPower3.1.2 software (Kiel University, Germany)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Respiratory Failure With Hypoxia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Noninvasive ventilation

Neurally Adjusted Ventilatory Assist versus Pressure Support flow triggered delivered by helmet

Group Type EXPERIMENTAL

Neurally Adjusted Ventilatory Assist

Intervention Type PROCEDURE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Neurally Adjusted Ventilatory Assist

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Infants aging \> 1 month and \< 2 years
* ARF (PaO2/FiO2 \< 300 mmHg, accessory muscle recruitment, Respiratory Rate more than 2 SD related to age),
* Intact neuromuscular pathway to the diaphragm

Exclusion Criteria

* Hemodynamic instability
* Reduction in airway protection
* Coma
* Contraindication to insert the nasogastric catheter
* Heart and/or lung transplant
* Increase in PIC
* Refusal of the parents or legal guardian

Minimum Eligible Age

1 Month

Maximum Eligible Age

24 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No